Brokers REVEAL New Rating and Price Target For Solta Medical
Wall St. Watchdog reveals information about companies for which stock analysts initiated coverage on July 5th.
Solta Medical (NASDAQ:SLTM): Ascendiant Capital Markets initiated coverage of this company with a rating of Buy and a price target of $3.5.
Don’t Miss: Here’s Why Apple is SMILING After the Fireworks.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.